These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 31266632)
1. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice. Li Y; Sun JP; Wang J; Lu WH; Xie LY; Lv J; Li HX; Yang SF Biochem Biophys Res Commun; 2019 Aug; 516(3):858-865. PubMed ID: 31266632 [TBL] [Abstract][Full Text] [Related]
2. GCSF deficiency attenuates nonalcoholic fatty liver disease through regulating GCSFR-SOCS3-JAK-STAT3 pathway and immune cells infiltration. Zhang Y; Zhou X; Liu P; Chen X; Zhang J; Zhang H; Li S; Chen Y; Song X; Wang J; Zeng H; Zhang X; Tang C; Yu C; Li Y; Xu C Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G531-G542. PubMed ID: 33470903 [TBL] [Abstract][Full Text] [Related]
3. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions. Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914 [TBL] [Abstract][Full Text] [Related]
4. Macrophage-specific FGFR1 deletion alleviates high-fat-diet-induced liver inflammation by inhibiting the MAPKs/TNF pathways. Zhao YN; Liu ZD; Yan T; Xu TX; Jin TY; Jiang YS; Zuo W; Lee KY; Huang LJ; Wang Y Acta Pharmacol Sin; 2024 May; 45(5):988-1001. PubMed ID: 38279043 [TBL] [Abstract][Full Text] [Related]
5. CD38 Deficiency Protects Mice from High Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Activating NAD Xie L; Wen K; Li Q; Huang CC; Zhao JL; Zhao QH; Xiao YF; Guan XH; Qian YS; Gan L; Wang LF; Deng KY; Xin HB Int J Biol Sci; 2021; 17(15):4305-4315. PubMed ID: 34803499 [TBL] [Abstract][Full Text] [Related]
6. A dietary ketone ester mitigates histological outcomes of NAFLD and markers of fibrosis in high-fat diet fed mice. Moore MP; Cunningham RP; Davis RAH; Deemer SE; Roberts BM; Plaisance EP; Rector RS Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G564-G572. PubMed ID: 33501889 [TBL] [Abstract][Full Text] [Related]
7. Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis. Zhang X; Li S; Zhou Y; Su W; Ruan X; Wang B; Zheng F; Warner M; Gustafsson JÅ; Guan Y Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3181-3185. PubMed ID: 28270609 [TBL] [Abstract][Full Text] [Related]
8. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder. Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955 [No Abstract] [Full Text] [Related]
9. Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages. Drummer C; Saaoud F; Jhala NC; Cueto R; Sun Y; Xu K; Shao Y; Lu Y; Shen H; Yang L; Zhou Y; Yu J; Wu S; Snyder NW; Hu W; Zhuo J'; Zhong Y; Jiang X; Wang H; Yang X Front Immunol; 2023; 14():1113883. PubMed ID: 36776889 [TBL] [Abstract][Full Text] [Related]
10. iRhom2 Promotes Hepatic Steatosis by Activating MAP3K7-Dependent Pathway. Xu M; Ge C; Zhu L; Qin Y; Du C; Lou D; Li Q; Hu L; Sun Y; Dai X; Xiong M; Long T; Zhan J; Kuang Q; Li H; Yang Q; Huang P; Teng X; Feng J; Wu Y; Dong W; Wang B; Tan J Hepatology; 2021 Apr; 73(4):1346-1364. PubMed ID: 32592194 [TBL] [Abstract][Full Text] [Related]
11. Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARγ expression. Li L; Fu J; Liu D; Sun J; Hou Y; Chen C; Shao J; Wang L; Wang X; Zhao R; Wang H; Andersen ME; Zhang Q; Xu Y; Pi J Redox Biol; 2020 Feb; 30():101412. PubMed ID: 31901728 [TBL] [Abstract][Full Text] [Related]
12. GPR40 deficiency is associated with hepatic FAT/CD36 upregulation, steatosis, inflammation, and cell injury in C57BL/6 mice. Lu Z; Li Y; Syn WK; Li AJ; Ritter WS; Wank SA; Lopes-Virella MF; Huang Y Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E30-E42. PubMed ID: 33103454 [TBL] [Abstract][Full Text] [Related]
13. Assessing the combined impact of fatty liver-induced TGF-β1 and LPS-activated macrophages in fibrosis through a novel 3D serial section methodology. Ishiyama S; Hayatsu M; Toriumi T; Tsuda H; Watanabe K; Kasai H; Kishigami S; Mochizuki K; Mikami Y Sci Rep; 2024 May; 14(1):11404. PubMed ID: 38762616 [TBL] [Abstract][Full Text] [Related]
14. Knockout of l-Histidine Decarboxylase Prevents Cholangiocyte Damage and Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via Disrupted Histamine/Leptin Signaling. Kennedy L; Hargrove L; Demieville J; Bailey JM; Dar W; Polireddy K; Chen Q; Nevah Rubin MI; Sybenga A; DeMorrow S; Meng F; Stockton L; Alpini G; Francis H Am J Pathol; 2018 Mar; 188(3):600-615. PubMed ID: 29248461 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of Setdb2 promotes alternative activation of macrophages via the PI3K/Akt pathway to attenuate NAFLD after sleeve gastrectomy. Yu T; Wang L; Cheng Y; Zhang Y; Zhu J; Zhang G; Hu S Biochem Biophys Res Commun; 2024 Sep; 726():150264. PubMed ID: 38905784 [TBL] [Abstract][Full Text] [Related]
17. Lipotoxic hepatocyte derived LIMA1 enriched small extracellular vesicles promote hepatic stellate cells activation via inhibiting mitophagy. Li S; Yang F; Cheng F; Zhu L; Yan Y Cell Mol Biol Lett; 2024 May; 29(1):82. PubMed ID: 38822260 [TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine ameliorates high-fat diet-induced nonalcoholic fatty liver disease by targeting SCD1 in obesity mice. Tao L; Guo X; Xu M; Wang Y; Xie W; Chen H; Ma M; Li X Pharmacol Res Perspect; 2021 Feb; 9(1):e00700. PubMed ID: 33474802 [TBL] [Abstract][Full Text] [Related]
19. Single-cell transcriptome analysis of liver immune microenvironment changes induced by microplastics in mice with non-alcoholic fatty liver. Liu W; Li M; Guo H; Wei S; Xu W; Yan Y; Shi Y; Xu Z; Chang K; Wei G; Zhao S Sci Total Environ; 2024 Feb; 912():168308. PubMed ID: 37977403 [TBL] [Abstract][Full Text] [Related]
20. Group IVA Phospholipase A Kishinaka S; Kawashita E; Nishizaki T; Ishihara K; Akiba S Biol Pharm Bull; 2024; 47(5):1058-1065. PubMed ID: 38825533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]